![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Sigma-aldrich Corporation Saint Louis Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Trypsin, TPCK-treated, Product numbers T3053 and T3943, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-214 - Rev 04
This TSE Type CEP, issued on February 06, 2009, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 694 associated with this CEP further emphasizes